|
1 juny 2018 |
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
|
|
|
5 juny 2018 |
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
Cufà González, SÃlvia
; Corominas Faja, Bruna
; Vázquez MartÃn, Alejandro
; Oliveras Ferrarós, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
2021 |
Necessitats de les dones amb cà ncer de mama finalitzada la fase aguda del tractament: projecte de recerca qualitatiu |
Garcia Canovas, Marta
|
|
|
2011 |
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
Puig i Miquel, Teresa
; Aguilar, Helena
; Cufà González, SÃlvia
; Oliveras, Glòria
; Turrado, Carlos
; Ortega Gutiérrez, SÃlvia
; Benhamú, Bellinda
; López RodrÃguez, Maria Luz
; Urruticoechea, Ander
; Colomer, Ramon
|
|
|
|
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
Puig i Miquel, Teresa
; Aguilar, Helena
; Cufà González, SÃlvia
; Oliveras, Glòria
; Turrado, Carlos
; Ortega Gutiérrez, SÃlvia
; Benhamú, Bellinda
; López RodrÃguez, Maria Luz
; Urruticoechea, Ander
; Colomer, Ramon
|
|
|
|
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
Puig i Miquel, Teresa
; Aguilar, Helena
; Cufà González, SÃlvia
; Oliveras, Glòria
; Turrado, Carlos
; Ortega Gutiérrez, SÃlvia
; Benhamú, Bellinda
; López RodrÃguez, Maria Luz
; Urruticoechea, Ander
; Colomer, Ramon
|
|
|
1 juny 2018 |
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
|
|
|
5 juny 2018 |
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
Puig i Miquel, Teresa
; Aguilar, Helena
; Cufà González, SÃlvia
; Oliveras, Glòria
; Turrado, Carlos
; Ortega Gutiérrez, SÃlvia
; Benhamú, Bellinda
; López RodrÃguez, Maria Luz
; Urruticoechea, Ander
; Colomer, Ramon
|
|
|
|
A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells |
Vert Company, Anna
; Castro Gallegos, Jessica
; Ribó i Panosa, Marc
; Benito i Mundet, Antoni
; Vilanova i Brugués, Maria
|
|
|
|
A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells |
Vert Company, Anna
; Castro Gallegos, Jessica
; Ribó i Panosa, Marc
; Benito i Mundet, Antoni
; Vilanova i Brugués, Maria
|
|
|
1 juny 2018 |
A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells |
|
|
|
5 juny 2018 |
A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells |
Vert Company, Anna
; Castro Gallegos, Jessica
; Ribó i Panosa, Marc
; Benito i Mundet, Antoni
; Vilanova i Brugués, Maria
|
|
|
2016 |
A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells |
Vert Company, Anna
; Castro Gallegos, Jessica
; Ribó i Panosa, Marc
; Benito i Mundet, Antoni
; Vilanova i Brugués, Maria
|
|
|
|
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
Cuyà s, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; RodrÃguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
|
|
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
Cuyà s, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; RodrÃguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
|
1 juny 2018 |
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
|
|
|
5 juny 2018 |
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
Cuyà s, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; RodrÃguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
|
20 maig 2015 |
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
Cuyà s, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; RodrÃguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
|
15 febrer 2020 |
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
Cuyà s, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; RodrÃguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
|
|
Paper jugat pel receptor ErbB-3 (HER-3) en el desenvolupament i tractament del cà ncer |
Cortés i Andrés, AdriÃ
|
|
|
juny 2017 |
Paper jugat pel receptor ErbB-3 (HER-3) en el desenvolupament i tractament del cà ncer |
Cortés i Andrés, AdriÃ
|
|
|
novembre 2022 |
Photodynamic therapy as an alternative to progestogens in endometrial cancer grade 1A G1: multicenter clinical analysis |
Bosch Solanes, Cristina
|
|
|
|
Preclinical evaluation of fatty acid synthase and egfrinhibition in triple-negative breast cancer |
Giró Perafita, Ariadna
; Palomeras, Sònia
; Lum, David H.
; Blancafort, Adriana
; Viñas, Gemma
; Oliveras, Glòria
; Perez Bueno, Ferran
; Sarrats Carbó, Ariadna
; Welm, Alana L.
; Puig i Miquel, Teresa
|
|
|
|
Preclinical evaluation of fatty acid synthase and egfrinhibition in triple-negative breast cancer |
Giró Perafita, Ariadna
; Palomeras, Sònia
; Lum, David H.
; Blancafort, Adriana
; Viñas, Gemma
; Oliveras, Glòria
; Perez Bueno, Ferran
; Sarrats Carbó, Ariadna
; Welm, Alana L.
; Puig i Miquel, Teresa
|
|
|
1 juny 2018 |
Preclinical evaluation of fatty acid synthase and egfrinhibition in triple-negative breast cancer |
|
